These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16076044)

  • 1. [Use of the exogenous surfactant curosurf in combined therapy for acute respiratory failure in children after cardiosurgical interventions].
    Lobacheva GV; Khar'kin AV; Aksenov AV; Kvasnikov BB; Manerova AF; Bokeriia LA
    Anesteziol Reanimatol; 2005; (3):35-8. PubMed ID: 16076044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
    Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective medicated (normal saline and exogenous surfactant) bronchoalveolar lavage in severe aspiration syndrome in children.
    Marraro GA; Luchetti M; Spada C; Galassini E; Giossi M; Piero AM
    Pediatr Crit Care Med; 2007 Sep; 8(5):476-81. PubMed ID: 17693914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin.
    Calkovska A; Some M; Linderholm B; Curstedt T; Robertson B
    Pulm Pharmacol Ther; 2008; 21(2):393-400. PubMed ID: 18032077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
    Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
    Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant treatment of aspiration-induced lung injury in children.
    Matthay MA; Taeusch W
    Pediatr Crit Care Med; 2007 Sep; 8(5):505-6. PubMed ID: 17873790
    [No Abstract]   [Full Text] [Related]  

  • 10. A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study.
    Wolfler A; Piastra M; Amigoni A; Santuz P; Gitto E; Rossetti E; Tinelli C; Montani C; Savron F; Pizzi S; D'amato L; Mondardini MC; Conti G; De Silvestri A
    BMC Pediatr; 2019 Jun; 19(1):203. PubMed ID: 31215483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of premature infants intubated in the delivery room, submitted or not to porcine-derived lung surfactant therapy within the first hour of life.
    Lefort S; Diniz EM; Vaz FA
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):187-96. PubMed ID: 14694974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study].
    Verder H; Agertoft L; Albertsen P; Christensen NC; Curstedt T; Ebbesen F; Greisen G; Hobolth N; Holm V; Jacobsen T
    Ugeskr Laeger; 1992 Jul; 154(31):2136-9. PubMed ID: 1509593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome.
    Cogo PE; Facco M; Simonato M; Verlato G; Rondina C; Baritussio A; Toffolo GM; Carnielli VP
    Pediatrics; 2009 Nov; 124(5):e950-7. PubMed ID: 19822594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
    Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
    N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment].
    Andersen T; Holm HS; Kamper J
    Ugeskr Laeger; 2006 Oct; 168(43):3723-7. PubMed ID: 17069738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant therapy in full-term neonates with severe respiratory failure.
    Khammash H; Perlman M; Wojtulewicz J; Dunn M
    Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of Curosurf with premature infants--the prevention or treatment of the neonatal RDS].
    Iarŭkova N; Chernev T; Nikolov A
    Akush Ginekol (Sofiia); 1998; 37(3):12-4. PubMed ID: 10204257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.